Inpatient Fentanyl Addiction Treatment Centers

Fentanyl is roughly 50 times stronger than heroin and now dominates the illicit opioid supply in the United States. Inpatient treatment — combining medically supervised detox, residential therapy, and medication-assisted treatment — is the safest and most effective starting point for fentanyl use disorder.

Why Fentanyl Requires Inpatient Treatment

Three clinical realities make inpatient care the standard of care for fentanyl use disorder:

1. Withdrawal severity. Fentanyl produces high-magnitude tolerance because of its potency. When a patient stops using, withdrawal can begin within hours and reach peak severity faster and harder than withdrawal from heroin. Inpatient medical detox uses buprenorphine, comfort medications, and 24-hour monitoring to manage symptoms safely.
2. Buprenorphine induction complexity. Standard buprenorphine induction protocols can precipitate withdrawal in fentanyl users because of the way fentanyl distributes into body tissues. Modern inpatient programs use low-dose or micro-dosing induction protocols specifically designed for fentanyl patients — these protocols require medical supervision and are not practical in an outpatient setting.
3. Overdose risk during relapse. Tolerance to fentanyl drops sharply within days of abstinence. A relapse at the patient's previous use level frequently causes fatal overdose. Inpatient care removes the patient from the environment and supply during the most vulnerable window, then transitions them into long-term MAT and aftercare to protect against future relapse.

The Inpatient Fentanyl Treatment Program

Most inpatient fentanyl programs run 60 to 90 days — longer than the typical 30-day stay used for some other substances — because the severity of fentanyl use disorder, the difficulty of induction, and the relapse risk after discharge all benefit from longer structured care.

Phase 1: Medical Detox

The patient is admitted to a medically monitored detox unit, assessed by a physician, and started on buprenorphine using either a low-dose induction protocol (starting at 0.5 mg and titrating up over 5–7 days) or, in some hospital-based programs, a methadone-based protocol. Vital signs are monitored frequently. Comfort medications manage residual symptoms. The detox phase typically lasts 7 to 14 days for fentanyl users — slightly longer than for heroin.

Phase 2: Residential Rehab

Once medically stable, the patient enters the residential treatment phase: individual therapy (often trauma-focused), group therapy, education on the neurobiology of opioid addiction, family programming, psychiatric care for co-occurring conditions, and continued MAT. Many fentanyl patients also need treatment for the secondary harms of street fentanyl use — wound care, infection, malnutrition, hepatitis C screening, and HIV testing.

Phase 3: Discharge & Aftercare

Discharge planning starts in the first week. A typical aftercare plan includes continuation of MAT through a community provider (often monthly Sublocade or Brixadi injections to remove daily medication adherence as a relapse risk factor), step-down outpatient or partial hospitalization, sober living when home is unstable, ongoing psychiatric care, and connection to peer recovery support.

Medications Used for Fentanyl Treatment

• Buprenorphine — first-line MAT for fentanyl use disorder; usually initiated with a low-dose or micro-dosing protocol in an inpatient setting
• Sublocade / Brixadi — long-acting monthly buprenorphine injections, often started before discharge to remove daily adherence as a failure point
• Methadone — used in hospital-based detox programs and federally licensed opioid treatment programs for cases where buprenorphine is inadequate
• Vivitrol (extended-release naltrexone) — for patients who complete a full opioid washout and prefer a non-opioid medication
• Naloxone (Narcan) — every patient should be sent home with naloxone and family members trained to use it; this is standard of care for fentanyl-exposed populations

Insurance Coverage for Fentanyl Treatment

Inpatient fentanyl treatment is covered by most commercial health insurance plans under the federal Mental Health Parity and Addiction Equity Act. Major carriers — Blue Cross Blue Shield, Aetna, Cigna, UnitedHealthcare, Humana, Anthem — pay for inpatient detox and residential rehab when medically necessary. Coverage for fentanyl admissions is generally robust because the medical acuity is high and the cost of an unmanaged overdose is much higher than the cost of inpatient care. Read our complete insurance guide →